Most-Cited Full-Text Articles
http://jpet.aspetjournals.org/
for Journal of Pharmacology and Experimental Therapeutics. Most-cited rankings are recalculated at the beginning of the month and are based on citations to articles on this journal site from articles in other HighWire-hosted journals.2008-11-12<![CDATA[Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians]]>
http://jpet.aspetjournals.org/cgi/content/short/270/1/414?rss=1&ssource=mfc
Jul 1, 1994; 270:414-423 ]]>T Shimada, H Yamazaki, M Mimura, Y Inui, FP Guengerich1994-07-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors]]>
http://jpet.aspetjournals.org/cgi/content/short/295/1/139?rss=1&ssource=mfc
Oct 1, 2000; 295:139-145 ]]>Elisabeth Buchdunger, Catherine L. Cioffi, Norman Law, David Stover, Sayuri Ohno-Jones, Brian J. Druker, Nicholas B. Lydon2000-10-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates]]>
http://jpet.aspetjournals.org/cgi/content/short/218/3/739?rss=1&ssource=mfc
Sep 1, 1981; 218:739-749 ]]>LJ Ignarro, H Lippton, JC Edwards, WH Baricos, AL Hyman, PJ Kadowitz, CA Gruetter1981-09-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils]]>
http://jpet.aspetjournals.org/cgi/content/short/255/2/756?rss=1&ssource=mfc
Nov 1, 1990; 255:756-768 ]]>JE Bleasdale, NR Thakur, RS Gremban, GL Bundy, FA Fitzpatrick, RJ Smith, S Bunting1990-11-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[A METHOD FOR DETERMINING LOSS OF PAIN SENSATION]]>
http://jpet.aspetjournals.org/cgi/content/short/72/1/74?rss=1&ssource=mfc
May 1, 1941; 72:74-79 ARTICLES]]>FRED E. D''AMOUR, DONN L. SMITH1941-05-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes]]>
http://jpet.aspetjournals.org/cgi/content/short/265/3/1455?rss=1&ssource=mfc
Jun 1, 1993; 265:1455-1473 ]]>M Alkondon, EX Albuquerque1993-06-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness]]>
http://jpet.aspetjournals.org/cgi/content/short/253/2/688?rss=1&ssource=mfc
May 1, 1990; 253:688-697 ]]>RJ Smith, LM Sam, JM Justen, GL Bundy, GA Bala, JE Bleasdale1990-05-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist]]>
http://jpet.aspetjournals.org/cgi/content/short/270/1/228?rss=1&ssource=mfc
Jul 1, 1994; 270:228-235 ]]>M Clozel, V Breu, GA Gray, B Kalina, BM Loffler, K Burri, JM Cassal, G Hirth, M Muller, W Neidhart1994-07-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[A SIMPLIFIED METHOD OF EVALUATING DOSE-EFFECT EXPERIMENTS]]>
http://jpet.aspetjournals.org/cgi/content/short/96/2/99?rss=1&ssource=mfc
Jun 1, 1949; 96:99-113 ]]>J. T. LITCHFIELD JR., F. WILCOXON1949-06-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Post-Translational Control of Endothelial Nitric Oxide Synthase: Why Isn't Calcium/Calmodulin Enough?]]>
http://jpet.aspetjournals.org/cgi/content/short/299/3/818?rss=1&ssource=mfc
Dec 1, 2001; 299:818-824 PERSPECTIVES IN PHARMACOLOGY]]>David Fulton, Jean-Philippe Gratton, William C. Sessa2001-12-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog]]>
http://jpet.aspetjournals.org/cgi/content/short/197/3/517?rss=1&ssource=mfc
Jun 1, 1976; 197:517-532 ]]>WR Martin, CG Eades, JA Thompson, RE Huppler, PE Gilbert1976-06-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Effects of Specific Inhibition of Cyclooxygenase-2 on Sodium Balance, Hemodynamics, and Vasoactive Eicosanoids]]>
http://jpet.aspetjournals.org/cgi/content/short/289/2/735?rss=1&ssource=mfc
May 1, 1999; 289:735-741 ARTICLES]]>Francesca Catella-Lawson, Brendan McAdam, Briggs W. Morrison, Shiv Kapoor, Dean Kujubu, Lisa Antes, Kenneth C. Lasseter, Hui Quan, Barry J. Gertz, Garret A. Fitzgerald1999-05-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Cytochrome P450-Derived Arachidonic Acid Metabolism in the Rat Kidney: Characterization of Selective Inhibitors]]>
http://jpet.aspetjournals.org/cgi/content/short/284/3/966?rss=1&ssource=mfc
Mar 1, 1998; 284:966-973 PROSTAGLANDINS, LEUKOTRIENES AND OTHER EICOSANOIDS]]>Mong-Heng Wang, Elimor Brand-Schieber, Barbara A. Zand, Xuandai Nguyen, John R. Falck, Narayanan Balu, Michal Laniado Schwartzman1998-03-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function]]>
http://jpet.aspetjournals.org/cgi/content/short/279/3/1453?rss=1&ssource=mfc
Dec 1, 1996; 279:1453-1461 ]]>AM Badger, JN Bradbeer, B Votta, JC Lee, JL Adams, DE Griswold1996-12-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Characterization of Interintestinal and Intraintestinal Variations in Human CYP3A-Dependent Metabolism]]>
http://jpet.aspetjournals.org/cgi/content/short/283/3/1552?rss=1&ssource=mfc
Dec 1, 1997; 283:1552-1562 DRUG METABOLISM AND DISPOSITION]]>Mary F. Paine, Mehraneh Khalighi, Jeannine M. Fisher, Danny D. Shen, Kent L. Kunze, Christopher L. Marsh, James D. Perkins, Kenneth E. Thummel1997-12-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes]]>
http://jpet.aspetjournals.org/cgi/content/short/277/1/321?rss=1&ssource=mfc
Apr 1, 1996; 277:321-332 ]]>M Bourrie, V Meunier, Y Berger, G Fabre1996-04-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Differential inhibition of human prostaglandin endoperoxide H synthases- 1 and -2 by nonsteroidal anti-inflammatory drugs]]>
http://jpet.aspetjournals.org/cgi/content/short/271/2/927?rss=1&ssource=mfc
Nov 1, 1994; 271:927-934 ]]>O Laneuville, DK Breuer, DL Dewitt, T Hla, CD Funk, WL Smith1994-11-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide]]>
http://jpet.aspetjournals.org/cgi/content/short/262/2/809?rss=1&ssource=mfc
Aug 1, 1992; 262:809-817 ]]>E Carmeliet1992-08-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases]]>
http://jpet.aspetjournals.org/cgi/content/short/271/3/1705?rss=1&ssource=mfc
Dec 1, 1994; 271:1705-1712 ]]>P Patrignani, MR Panara, A Greco, O Fusco, C Natoli, S Iacobelli, F Cipollone, A Ganci, C Creminon, J Maclouf1994-12-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit]]>
http://jpet.aspetjournals.org/cgi/content/short/244/1/19?rss=1&ssource=mfc
Jan 1, 1988; 244:19-22 ]]>V Gisclard, VM Miller, PM Vanhoutte1988-01-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data]]>
http://jpet.aspetjournals.org/cgi/content/short/283/1/46?rss=1&ssource=mfc
Oct 1, 1997; 283:46-58 DRUG METABOLISM AND DISPOSITION]]>R. Scott Obach, James G. Baxter, Theodore E. Liston, B. Michael Silber, Barry C. Jones, Fiona Macintyre, David J. Rance, Philip Wastall1997-10-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. IV. PROTECTIVE ROLE OF GLUTATHIONE]]>
http://jpet.aspetjournals.org/cgi/content/short/187/1/211?rss=1&ssource=mfc
Oct 1, 1973; 187:211-217 ]]>J. R. Mitchell, D. J. Jollow, W. Z. Potter, J. R. Gillette, B. B. Brodie1973-10-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Inhibition of Epidermal Growth Factor Receptor-Associated Tyrosine Phosphorylation in Human Carcinomas with CP-358,774: Dynamics of Receptor Inhibition In Situ and Antitumor Effects in Athymic Mice]]>
http://jpet.aspetjournals.org/cgi/content/short/291/2/739?rss=1&ssource=mfc
Nov 1, 1999; 291:739-748 ARTICLES]]>Vincent A. Pollack, Douglas M. Savage, Deborah A. Baker, Konstantinos E. Tsaparikos, Donald E. Sloan, James D. Moyer, Elsa G. Barbacci, Leslie R. Pustilnik, Teresa A. Smolarek, John A. Davis, Madhur P. Vaidya, Lee D. Arnold, John L. Doty, Kenneth K. Iwata, Michael J. Morin1999-11-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Effects of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid omega-hydroxylase, on renal function in rats]]>
http://jpet.aspetjournals.org/cgi/content/short/268/1/474?rss=1&ssource=mfc
Jan 1, 1994; 268:474-481 ]]>AP Zou, YH Ma, ZH Sui, PR Ortiz de Montellano, JE Clark, BS Masters, RJ Roman1994-01-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Antagonist binding profiles of five cloned human muscarinic receptor subtypes]]>
http://jpet.aspetjournals.org/cgi/content/short/256/2/727?rss=1&ssource=mfc
Feb 1, 1991; 256:727-733 ]]>F Dorje, J Wess, G Lambrecht, R Tacke, E Mutschler, MR Brann1991-02-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values]]>
http://jpet.aspetjournals.org/cgi/content/short/251/1/238?rss=1&ssource=mfc
Oct 1, 1989; 251:238-246 ]]>HY Meltzer, S Matsubara, JC Lee1989-10-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Properties of Neuronal Nicotinic Acetylcholine Receptors: Pharmacological Characterization and Modulation of Synaptic Function,]]>
http://jpet.aspetjournals.org/cgi/content/short/280/3/1117?rss=1&ssource=mfc
Mar 1, 1997; 280:1117-1136 THE 1996 ASPET OTTO KRAYER AWARD LECTURE]]>Edson X. Albuquerque, Manickavasagom Alkondon, Edna F. R. Pereira, Newton G. Castro, Andre Schrattenholz, Catao T. F. Barbosa, Rafael Bonfante-Cabarcas, Yasco Aracava, Howard M. Eisenberg, Alfred Maelicke1997-03-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man]]>
http://jpet.aspetjournals.org/cgi/content/short/275/1/94?rss=1&ssource=mfc
Oct 1, 1995; 275:94-100 ]]>Z Wang, G Ciabattoni, C Creminon, J Lawson, GA Fitzgerald, C Patrono, J Maclouf1995-10-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Cloning and characterization of a rat H+/peptide cotransporter mediating absorption of beta-lactam antibiotics in the intestine and kidney]]>
http://jpet.aspetjournals.org/cgi/content/short/275/3/1631?rss=1&ssource=mfc
Dec 1, 1995; 275:1631-1637 ]]>H Saito, M Okuda, T Terada, S Sasaki, K Inui1995-12-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion]]>
http://jpet.aspetjournals.org/cgi/content/short/260/2/668?rss=1&ssource=mfc
Feb 1, 1992; 260:668-675 ]]>MR Siegfried, J Erhardt, T Rider, XL Ma, AM Lefer1992-02-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2]]>
http://jpet.aspetjournals.org/cgi/content/short/265/1/401?rss=1&ssource=mfc
Apr 1, 1993; 265:401-407 ]]>W Tassaneeyakul, DJ Birkett, ME Veronese, ME McManus, RH Tukey, LC Quattrochi, HV Gelboin, JO Miners1993-04-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Selective blockade of endothelium-dependent and glyceryl trinitrate- induced relaxation by hemoglobin and by methylene blue in the rabbit aorta]]>
http://jpet.aspetjournals.org/cgi/content/short/232/3/708?rss=1&ssource=mfc
Mar 1, 1985; 232:708-716 ]]>W Martin, GM Villani, D Jothianandan, RF Furchgott1985-03-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues]]>
http://jpet.aspetjournals.org/cgi/content/short/253/1/387?rss=1&ssource=mfc
Apr 1, 1990; 253:387-394 ]]>I de Waziers, PH Cugnenc, CS Yang, JP Leroux, PH Beaune1990-04-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor]]>
http://jpet.aspetjournals.org/cgi/content/short/284/2/644?rss=1&ssource=mfc
Feb 1, 1998; 284:644-650 CELLULAR AND MOLECULAR PHARMACOLOGY]]>Murielle Rinaldi-Carmona, Francis Barth, Jose Millan, Jean-Marie Derocq, Pierre Casellas, Christian Congy, Didier Oustric, Martine Sarran, Monsif Bouaboula, Bernard Calandra, Marielle Portier, David Shire, Jean-Claude Breliere, Gerard Le Fur1998-02-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[DOPAMINERGIC NEURONS: EFFECT OF ANTIPSYCHOTIC DRUGS AND AMPHETAMINE ON SINGLE CELL ACTIVITY]]>
http://jpet.aspetjournals.org/cgi/content/short/185/3/560?rss=1&ssource=mfc
Jun 1, 1973; 185:560-571 ]]>BENJAMIN S. BUNNEY, JUDITH R. WALTERS, ROBERT H. ROTH, GEORGE K. AGHAJANIAN1973-06-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts]]>
http://jpet.aspetjournals.org/cgi/content/short/264/1/135?rss=1&ssource=mfc
Jan 1, 1993; 264:135-144 ]]>GD Lopaschuk, RB Wambolt, RL Barr1993-01-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Glycyrrhetinic acid derivatives: a novel class of inhibitors of gap- junctional intercellular communication. Structure-activity relationships]]>
http://jpet.aspetjournals.org/cgi/content/short/246/3/1104?rss=1&ssource=mfc
Sep 1, 1988; 246:1104-1107 ]]>JS Davidson, IM Baumgarten1988-09-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Pharmacological Characterization of Recombinant Human Neuronal Nicotinic Acetylcholine Receptors halpha 2beta 2, halpha 2beta 4, halpha 3beta 2, halpha 3beta 4, halpha 4beta 2, halpha 4beta 4 and halpha 7 Expressed in Xenopus Oocytes]]>
http://jpet.aspetjournals.org/cgi/content/short/280/1/346?rss=1&ssource=mfc
Jan 1, 1997; 280:346-356 CELLULAR AND MOLECULAR PHARMACOLOGY]]>Laura E. Chavez-Noriega, James H. Crona, Mark S. Washburn, Arturo Urrutia, Kathryn J. Elliott, Edwin C. Johnson1997-01-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Adenosine A2 Receptor Activation Attenuates Reperfusion Injury by Inhibiting Neutrophil Accumulation, Superoxide Generation and Coronary Endothelial Adherence]]>
http://jpet.aspetjournals.org/cgi/content/short/280/1/301?rss=1&ssource=mfc
Jan 1, 1997; 280:301-309 CARDIOVASCULAR PHARMACOLOGY]]>James E. Jordan, Zhi-Qing Zhao, Hiroki Sato, Spencer Taft, Jakob Vinten-Johansen1997-01-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach]]>
http://jpet.aspetjournals.org/cgi/content/short/274/3/1531?rss=1&ssource=mfc
Sep 1, 1995; 274:1531-1537 ]]>CC Chan, S Boyce, C Brideau, AW Ford-Hutchinson, R Gordon, D Guay, RG Hill, CS Li, J Mancini, M Penneton1995-09-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Peroxynitrite, a product of superoxide and nitric oxide, produces coronary vasorelaxation in dogs]]>
http://jpet.aspetjournals.org/cgi/content/short/268/3/1114?rss=1&ssource=mfc
Mar 1, 1994; 268:1114-1121 ]]>S Liu, JS Beckman, DD Ku1994-03-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist]]>
http://jpet.aspetjournals.org/cgi/content/short/276/2/473?rss=1&ssource=mfc
Feb 1, 1996; 276:473-481 ]]>TJ Opgenorth, AL Adler, SV Calzadilla, WJ Chiou, BD Dayton, DB Dixon, LJ Gehrke, L Hernandez, SR Magnuson, KC Marsh, EI Novosad, TW Von Geldern, JL Wessale, M Winn, JR Wu-Wong1996-02-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. II. ROLE OF COVALENT BINDING IN VIVO]]>
http://jpet.aspetjournals.org/cgi/content/short/187/1/195?rss=1&ssource=mfc
Oct 1, 1973; 187:195-202 ]]>D. J. Jollow, J. R. Mitchell, W. Z. Potter, D. C. Davis, J. R. Gillette, B. B. Brodie1973-10-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Rofecoxib [Vioxx, MK-0966; 4-(4'-Methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: A Potent and Orally Active Cyclooxygenase-2 Inhibitor. Pharmacological and Biochemical Profiles]]>
http://jpet.aspetjournals.org/cgi/content/short/290/2/551?rss=1&ssource=mfc
Aug 1, 1999; 290:551-560 ARTICLES]]>C.-C. Chan, S. Boyce, C. Brideau, S. Charleson, W. Cromlish, D. Ethier, J. Evans, A. W. Ford-Hutchinson, M. J. Forrest, J. Y. Gauthier, R. Gordon, M. Gresser, J. Guay, S. Kargman, B. Kennedy, Y. Leblanc, S. Leger, J. Mancini, G. P. O''Neill, M. Ouellet, D. Patrick, M. D. Percival, H. Perrier, P. Prasit, I. Rodger, P. Tagari, M. Therien, P. Vickers, D. Visco, Z. Wang, J. Webb, E. Wong, L.-J. Xu, R. N. Young, R. Zamboni, D. Riendeau1999-08-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[A Major Role for CYP2A6 in Nicotine C-Oxidation by Human Liver Microsomes]]>
http://jpet.aspetjournals.org/cgi/content/short/282/3/1608?rss=1&ssource=mfc
Sep 1, 1997; 282:1608-1614 DRUG METABOLISM AND DISPOSITION]]>E. S. Messina, R. F. Tyndale, E. M. Sellers1997-09-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Expression and Localization of Multidrug Resistant Protein mrp2 in Rat Small Intestine]]>
http://jpet.aspetjournals.org/cgi/content/short/293/3/717?rss=1&ssource=mfc
Jun 1, 2000; 293:717-723 GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL]]>Aldo D. Mottino, Tim Hoffman, Lothar Jennes, Mary Vore2000-06-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Fetal Nicotine or Cocaine Exposure: Which One is Worse?]]>
http://jpet.aspetjournals.org/cgi/content/short/285/3/931?rss=1&ssource=mfc
Jun 1, 1998; 285:931-945 THE 1998 ASPET OTTO KRAYER AWARD LECTURE]]>Theodore A. Slotkin1998-06-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. I. ROLE OF DRUG METABOLISM]]>
http://jpet.aspetjournals.org/cgi/content/short/187/1/185?rss=1&ssource=mfc
Oct 1, 1973; 187:185-194 ]]>J. R. Mitchell, D. J. Jollow, W. Z. Potter, D. C. Davis, J. R. Gillette, B. B. Brodie1973-10-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs]]>
http://jpet.aspetjournals.org/cgi/content/short/264/1/475?rss=1&ssource=mfc
Jan 1, 1993; 264:475-479 ]]>C Jin, JO Miners, KJ Lillywhite, PI Mackenzie1993-01-01American Society for Pharmacology and Experimental Therapeutics<![CDATA[Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger]]>
http://jpet.aspetjournals.org/cgi/content/short/263/1/92?rss=1&ssource=mfc
Oct 1, 1992; 263:92-98 ]]>TL Yue, HY Cheng, PG Lysko, PJ McKenna, R Feuerstein, JL Gu, KA Lysko, LL Davis, G Feuerstein1992-10-01American Society for Pharmacology and Experimental Therapeutics